ই-মেইল নথি: MTR-02 MGMT-INHIBITOR IN COMBINATION WITH TGF-β KINASE OR CDK 4/6 INHIBITOR INCREASES TEMOZOLOMIDE SENSITIVITY OF TEMOZOLOMIDE RESISTANT GLIOBLASTOMA CELLS

এখানে:

বার্তা: